Dan Zweifel serves as the Director of Clinical Pharmacology and Translational Medicine at Prothena Corporation plc. His career is distinguished by expertise in drug development, bioanalytical techniques, and PK/PD modeling. He holds a Doctorate of Pharmacy alongside Masters degrees from Clemson University in Bioanalytical Chemistry and Materials Science.
His unique academic background combines advanced pharmacology with a Masters degree in Materials Science and Engineering, an interdisciplinary skill set.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.